Encounter for antenatal screening for Streptococcus B
ICD-10 Z36.85 is a billable code used to indicate a diagnosis of encounter for antenatal screening for streptococcus b.
Z36.85 is used to indicate an encounter for antenatal screening specifically for Group B Streptococcus (GBS), a common bacterium that can be found in the vagina or rectum of healthy women. Screening for GBS is a critical preventive measure during pregnancy, as it can significantly impact maternal and neonatal health. The screening typically occurs between 35 and 37 weeks of gestation and is essential for identifying women who may transmit the bacteria to their newborns during delivery. Factors influencing health status include access to prenatal care, socioeconomic status, and education level, which can affect a woman's likelihood of receiving timely screening. Social determinants such as housing stability, transportation access, and health literacy also play a role in ensuring that expectant mothers engage with healthcare services for necessary screenings. Preventive care through GBS screening can lead to interventions such as intrapartum antibiotic prophylaxis, reducing the risk of early-onset GBS disease in infants. Proper documentation of the encounter is crucial for coding accuracy and ensuring that the healthcare provider receives appropriate reimbursement for preventive services.
Documentation must include the date of the screening, gestational age, and any patient education provided regarding GBS.
Routine prenatal visits where GBS screening is performed, including discussions about the implications of positive results.
Consideration of social determinants such as access to care and education about GBS.
Documentation should include population-level data on GBS screening rates and outcomes.
Public health initiatives aimed at increasing awareness and screening rates for GBS among pregnant women.
Focus on tracking health disparities and access to screening services.
Used during the encounter for GBS screening at 35-37 weeks of gestation.
Documentation must include the date of the test, results, and any follow-up care provided.
Primary care providers should ensure that the screening aligns with current guidelines.
GBS screening is crucial as it helps identify pregnant women who carry the bacteria, allowing for timely interventions to prevent transmission to the newborn during delivery. This can significantly reduce the risk of serious infections in infants.
